Surgical ventricular reconstruction with endocardectomy along radiofrequency ablation-induced markings

Бабокин, В. Е.; Shipulin, V. M.; Баталов, Р. И.; Попов, С. В.

doi:10.1016/j.jtcvs.2012.08.067

Cited by 19 publications

(18 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Тради-ционным методом лечения аортальных пороков является протезирование аортального клапана меха-ническими и биологическими протезами. Современ-ный уровень развития кардиохирургии и анестезио-логии позволил уменьшить показатели летальности и периоперационных осложнений до минимальных значений [3]. В России в последние годы отмечается тенденция к увеличению количества хирургических вмешательств при клапанных пороках сердца [4,5].…”

unclassified

Long‐term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement

Lardizabal

Macon

O’Neill

et al. 2015

Cathet Cardio Intervent

View full text Add to dashboard Cite

Objective We investigated the long‐term safety, efficacy and clinical outcomes associated with transaortic (TAO) transcatheter aortic valve replacement (TAVR) in the United States. Background We previously reported the technical feasibility and short‐term safety of TAO TAVR. Compared to transapical (TAP) access, the TAO approach was associated with shorter median intensive care unit (ICU) length of stay (LOS) and more favorable technical learning curve. However, outcomes data beyond 30 days were lacking and the longer‐term clinical consequences of this strategy were unknown. Methods Mortality outcomes at 1 year (and longer) of 44 consecutive patients who underwent TAO TAVR in our institution were compared with that of 76 consecutive patients who underwent TAP TAVR at our site. Risk‐adjusted analysis was performed in propensity‐matched patients (25 from each group) to account for baseline differences. Results TAO TAVR was associated with a trend towards lower all‐cause mortality at 1 year compared to TAP TAVR (18% vs. 34%, P=0.09 in the overall sample; 12% vs. 40%, P = 0.05 in the matched cohort). The higher probability of survival with TAO TAVR persisted after a median follow‐up period of 23 months (hazard ratio [HR]=1.96, P = 0.06 in the overall sample; HR = 3.4, P = 0.01 in the matched cohort). Cardiovascular mortality at 1 year was lower with TAO TAVR (2% vs. 22%, P = 0.01 in the overall sample; 4% vs. 28%, P = 0.05 in the matched cohort). ICU LOS (shorter in the TAO group) and implantation of second prosthetic valve (higher incidence in the TAP group) were independent predictors of long‐term mortality. Conclusion The outcomes associated with TAO TAVR compare favorably with TAP TAVR. Our results appear to corroborate the long‐term safety and efficacy of the TAO approach in TAVR patients with inadequate iliofemoral access. © 2015 Wiley Periodicals, Inc.

show abstract

unclassified

Long‐term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement

Lardizabal

Macon

O’Neill

et al. 2015

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…Немаловажным является и выполнение процедуры эндокардэктомии при выполнении процедуры ХРЛЖ. Эндокардэктомия играет важную роль в предотвращении послеоперационной желудочковой тахикардии [43]. Предоперационная радиочастотная маркировка зон re-entry позволила значительно улучшить результаты эндокардэктомии при ХРЛЖ [43].…”

Section: реконструкция лж при икмпunclassified

Surgical Treatment of Ischemic Cardiomyopathy: Current State of the Problem

et al. 2019

View full text Add to dashboard Cite

In this article we present discussion of the current state of the problem of surgical treatment of ischemic cardiomyopathy (ICM). The pathophysiological aspects of left ventricular remodeling in patients with ICM are also covered. A detailed characterization of methods for assessing the myocardial viability is given and their role in patients with ICM is shown. The problem of right ventricular dysfunction in ICM is discussed. Main attention is focused on the methods of surgical treatment of ICM. Limitations of the Surgical Treatment for Ischemic Heart Failure (STICH) study are analyzed. The article is intended for cardiologists, general practitioners and cardiac surgeons.

show abstract

“…3 Given the high incidence of malignant arrhythmias, addition of ablation of the LV border zone and endocardectomy during surgical ventricular reconstruction has been advocated. 4,5 The results of these procedures have been suboptimal, however, and the rate of arrhythmia recurrence remains high, with most patients benefiting from implantable cardioverter defibrillator placement. Although electrical isolation of the border zone from the remaining ''healthy'' ventricular myocardium is an appealing concept to prevent propagation of the arrhythmias, execution has been difficult.…”

mentioning

confidence: 99%

Commentary: Not cool enough—Surgical cryoablation during ventricular reconstruction

Killu

Crestanello

2019

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

Surgical ventricular reconstruction with endocardectomy along radiofrequency ablation-induced markings

Cited by 19 publications

References 18 publications

Long‐term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement

Long‐term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement

Surgical Treatment of Ischemic Cardiomyopathy: Current State of the Problem

Commentary: Not cool enough—Surgical cryoablation during ventricular reconstruction

Contact Info

Product

Resources

About